Cole Douglas G. 4
4 · Foghorn Therapeutics Inc. · Filed Jun 25, 2026
Research Summary
AI-generated summary of this filing
Foghorn (FHTX) Director Douglas G. Cole Receives 28,000-Share Award
What Happened
Douglas G. Cole, a member of Foghorn Therapeutics' board of directors, was granted a derivative award for 28,000 shares on 2026-06-24. The grant is reported at $4.08 per share, for a reported value of $114,240. This was an award/derivative grant (not an open-market purchase or sale).
Key Details
- Transaction date: 2026-06-24; Form 4 filed: 2026-06-25 (appears timely).
- Transaction type/code: Award/Grant (A); reported as a derivative grant.
- Reported price/value: $4.08 per share; total reported value $114,240.
- Vesting: Footnote — the option/award vests in full on the first anniversary of the grant date, subject to continued board service.
- Shares owned after transaction: Not specified in the provided filing summary.
Context
This grant is a compensation-related derivative award that vests one year after grant if Mr. Cole remains a director. Such awards do not represent an immediate open-market purchase or sale of common stock and may not reflect immediate trading intent. For retail investors, grants signal board compensation but are not direct market buys; monitor future filings for vesting/exercise or sales.
Insider Transaction Report
- Award
Stock Options (Right to buy)
[F1]2026-06-24$4.08/sh+28,000$114,240→ 28,000 totalExercise: $4.08Exp: 2036-06-23→ Common Stock (28,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors.